ENTRY       D10261            Mixture   Drug
NAME        Metformin hydrochloride and sitagliptin phosphate;
            Janumet (TN)
PRODUCT     JANUMET (A-S Medication Solutions)
            JANUMET (A-S Medication Solutions)
            JANUMET (A-S Medication Solutions)
            JANUMET (A-S Medication Solutions)
            JANUMET (A-S Medication Solutions)
            JANUMET (Merck Sharp & Dohme LLC)
            JANUMET (Merck Sharp & Dohme LLC)
            JANUMET XR (A-S Medication Solutions)
COMPONENT   Metformin hydrochloride [DR:D00944], (Sitagliptin phosphate hydrate [DR:D06645] | Sitagliptin [DR:D08516] | Sitagliptin phosphate [DR:D12294])
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03032  Combination of metformin and DPP-4 inhibitor
REMARK      ATC code: A10BD07
            Product: D10261<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD07 Metformin and sitagliptin
                  D10261  Metformin hydrochloride and sitagliptin phosphate &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Sitagliptin/ Metformin Hydrochloride
                D10261  Metformin hydrochloride and sitagliptin phosphate
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03032  Combination of metformin and DPP-4 inhibitor
                D10261  Metformin hydrochloride and sitagliptin phosphate
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10261  Metformin hydrochloride and sitagliptin phosphate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10261
DBLINKS     PubChem: 163312292
///
